Antibody Research
Private Company
Funding information not available
Overview
Antibody Research is a long-established, privately-held biotech service provider and reagent supplier focused on the antibody and protein research market. The company operates a hybrid business model, selling a catalog of off-the-shelf antibodies, proteins, cell lines, tissues, reagents, and ELISA kits while also offering comprehensive custom service capabilities including hybridoma development, antibody production, and assay development. With a direct sales and distributor network serving an international clientele, the company appears to be a revenue-generating entity catering primarily to academic, pharmaceutical, and biotech research labs. Its strategic focus remains on leveraging core technological expertise in antibody generation and protein sciences to support its clients' research and development efforts.
Technology Platform
Hybridoma technology for monoclonal antibody development, complemented by recombinant protein expression, cell line services, conjugation/labeling, and assay development. Offers multi-host production (mice, rats, rabbits, goats, alpaca, etc.) and scale-up using hollow fiber bioreactors.
Opportunities
Risk Factors
Competitive Landscape
Operates in a highly competitive and fragmented market dominated by global giants like Thermo Fisher Scientific, Abcam, and Merck Millipore, which offer vast catalogs and resources. Competes with numerous smaller, specialized CROs and reagent suppliers on the basis of personalized service, technical expertise in specific areas (e.g., multi-host immunization), and flexibility in custom project work.